Literature DB >> 23335710

[Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012].

León Schurman1, Alicia Bagur, Haraldo Claus-Hermberg, Osvaldo D Messina, Armando L Negri, Ariel Sánchez, Claudio González, María Diehl, Paula Rey, Julieta Gamba, Javier Chiarpenello, María Susana Moggia, Silvina Mastaglia.   

Abstract

Osteoporosis is a constantly growing disease which affects over 200 million people worldwide. The present recommendations are guidelines for its diagnosis, prevention and treatment, but they do not constitute standards for clinical decisions in individual patients. The physician must adapt them to individual patients and special situations, incorporating personal factors that transcend the limits of these guidelines and are dependent on the knowledge and art of the physician. These guidelines should be reviewed and updated periodically as new, better and more effective diagnostic and therapeutic tools become available.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335710

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  10 in total

1.  Isopsoralen ameliorates H2O2-induced damage in osteoblasts via activating the Wnt/β-catenin pathway.

Authors:  Yu-Peng Li; Bin Wu; Jie Liang; Fei Li
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

Review 2.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

3.  The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people-a retrospective case-control study in Argentina.

Authors:  H A Perroud; M S Dagatti; B Amigot; G P Levit; M F Tomat; M E Morosano; A M Masoni; S M Pezzotto
Journal:  J Bone Miner Metab       Date:  2016-04-02       Impact factor: 2.626

4.  Normalization of bone mineral density after five years of treatment with strontium ranelate.

Authors:  Julio Ariel Sánchez
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

5.  Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults.

Authors:  H-T Ning; Y Du; L-J Zhao; Q Tian; H Feng; H-W Deng
Journal:  Osteoporos Int       Date:  2020-11-24       Impact factor: 4.507

6.  Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment.

Authors:  Lucas R Brun; Ana M Galich; Eduardo Vega; Helena Salerni; Laura Maffei; Valeria Premrou; Pablo R Costanzo; Marcelo A Sarli; Paula Rey; María S Larroudé; María S Moggia; María L Brance; Ariel Sánchez
Journal:  Springerplus       Date:  2014-11-18

7.  Isopsoralen-mediated suppression of bone marrow adiposity and attenuation of the adipogenic commitment of bone marrow-derived mesenchymal stem cells.

Authors:  Jian Wang; Sheng-Fa Li; Ting Wang; Chun-Han Sun; Liang Wang; Min-Jun Huang; Jian Chen; Shao-Wei Zheng; Nan Wang; Ying-Jun Zhang; Tian-Yu Chen
Journal:  Int J Mol Med       Date:  2017-02-06       Impact factor: 4.101

Review 8.  Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines.

Authors:  Roberto Coronado-Zarco; Andrea Olascoaga-Gómez de León; Araceli García-Lara; Jimena Quinzaños-Fresnedo; Tania Inés Nava-Bringas; Salvador Israel Macías-Hernández
Journal:  Osteoporos Sarcopenia       Date:  2019-10-04

9.  Association of hemoglobin levels with bone mineral density for adults over 18 years of age: a cross-sectional study.

Authors:  Enqi Liu; Xinzheng Hou; Siqi Liu; Jing Han; Hao Lv
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

10.  Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis.

Authors:  A Sánchez; L R Brun; H Salerni; P R Costanzo; D González; A Bagur; B Oliveri; M B Zanchetta; V Farías; L Maffei; V Premrou; J L Mansur; M S Larroudé; M A Sarli; P Rey; M R Ulla; M M Pavlove; S Karlsbrum; M L Brance
Journal:  J Osteoporos       Date:  2016-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.